British-Swedish pharmaceutical company AstraZeneca said Friday that it will start to book a modest profit from its coronavirus vaccine as it moves away from the nonprofit model it has operated during the pandemic.

Join The Ecosystem

Leave a Reply

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}